Phosphodiesterase 5 Inhibitor [EPC]

Phosphodiesterase 5 Inhibitor [EPC] was reported 135416 times

These side effects are most commonly reported by patients taking drugs of the Phosphodiesterase 5 Inhibitor [EPC] class:

# Drug class Count
0 DYSPNOEA 16396
1 HEADACHE 13856
2 DIARRHOEA 10353
3 NAUSEA 8855
4 DEATH 8680
5 FATIGUE 8234
6 DRUG INEFFECTIVE 7337
7 DIZZINESS 7112
8 PNEUMONIA 5955
9 COUGH 5747
10 MALAISE 4983
11 VOMITING 4923
12 OFF LABEL USE 4561
13 PAIN 4512
14 HYPOTENSION 4404
15 PAIN IN EXTREMITY 4340
16 ASTHENIA 4311
17 PULMONARY ARTERIAL HYPERTENSION 4240
18 FLUID RETENTION 4228
19 CHEST PAIN 3751
20 FLUSHING 3506
21 CONDITION AGGRAVATED 3345
22 BACK PAIN 3277
23 FALL 3195
24 DYSPNOEA EXERTIONAL 3163
25 PAIN IN JAW 3119
26 OXYGEN SATURATION DECREASED 3111
27 OEDEMA PERIPHERAL 3105
28 ARTHRALGIA 3083
29 WEIGHT DECREASED 3082
30 PERIPHERAL SWELLING 3021
31 SYNCOPE 2969
32 NASAL CONGESTION 2866
33 PYREXIA 2855
34 PULMONARY HYPERTENSION 2751
35 MYALGIA 2732
36 NASOPHARYNGITIS 2594
37 FEELING ABNORMAL 2586
38 INFUSION SITE PAIN 2528
39 DECREASED APPETITE 2513
40 PALPITATIONS 2280
41 ANAEMIA 2265
42 HOSPITALISATION 2258
43 OEDEMA 2249
44 CARDIAC FAILURE 2240
45 WEIGHT INCREASED 2229
46 INSOMNIA 2108
47 HYPERTENSION 2062
48 RASH 1993
49 ABDOMINAL DISCOMFORT 1980
50 ABDOMINAL PAIN UPPER 1969
51 ANXIETY 1967
52 CHEST DISCOMFORT 1890
53 EPISTAXIS 1842
54 RIGHT VENTRICULAR FAILURE 1820
55 ABDOMINAL PAIN 1744
56 ATRIAL FIBRILLATION 1701
57 MUSCLE SPASMS 1693
58 CARDIAC FAILURE CONGESTIVE 1630
59 VISION BLURRED 1627
60 LOSS OF CONSCIOUSNESS 1614
61 PRURITUS 1569
62 HYPOXIA 1565
63 CONSTIPATION 1558
64 HEART RATE INCREASED 1554
65 PRODUCT DOSE OMISSION ISSUE 1554
66 RESPIRATORY FAILURE 1543
67 INFUSION SITE ERYTHEMA 1501
68 ABDOMINAL DISTENSION 1476
69 INFLUENZA 1455
70 CARDIAC DISORDER 1428
71 DRUG DOSE OMISSION 1423
72 DYSPEPSIA 1421
73 DEPRESSION 1415
74 RENAL FAILURE 1399
75 PULMONARY OEDEMA 1397
76 DEHYDRATION 1394
77 URINARY TRACT INFECTION 1389
78 UNEVALUABLE EVENT 1348
79 SWELLING 1336
80 FLUID OVERLOAD 1335
81 DISEASE PROGRESSION 1297
82 ACUTE KIDNEY INJURY 1289
83 BLOOD PRESSURE DECREASED 1288
84 COVID-19 1281
85 SEPSIS 1272
86 ERYTHEMA 1248
87 SOMNOLENCE 1248
88 PRODUCT USE ISSUE 1233
89 VISUAL IMPAIRMENT 1211
90 HAEMOGLOBIN DECREASED 1189
91 GASTROOESOPHAGEAL REFLUX DISEASE 1181
92 HOT FLUSH 1168
93 THERAPY NON-RESPONDER 1168
94 GAIT DISTURBANCE 1161
95 DEVICE RELATED INFECTION 1150
96 OROPHARYNGEAL PAIN 1137
97 INFECTION 1122
98 PRODUCTIVE COUGH 1112
99 CHILLS 1073
100 ERECTILE DYSFUNCTION 1067
101 MIGRAINE 1054
102 SINUSITIS 1051
103 PLEURAL EFFUSION 1040
104 DRUG INTERACTION 1038
105 BRONCHITIS 1008
106 GASTROINTESTINAL HAEMORRHAGE 1002
107 DERMATITIS CONTACT 965
108 MYOCARDIAL INFARCTION 959
109 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 952
110 DEVICE DISLOCATION 932
111 BLOOD PRESSURE INCREASED 921
112 JOINT SWELLING 918
113 BLOOD CHOLESTEROL INCREASED 907
114 CEREBROVASCULAR ACCIDENT 907
115 CARDIAC ARREST 905
116 TACHYCARDIA 898
117 CONFUSIONAL STATE 894
118 RHINORRHOEA 894
119 THERAPEUTIC RESPONSE DECREASED 892
120 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 874
121 HYPERSENSITIVITY 874
122 TREMOR 874
123 INFUSION SITE SWELLING 870
124 GENERAL PHYSICAL HEALTH DETERIORATION 868
125 THROAT IRRITATION 867
126 GASTROINTESTINAL DISORDER 860
127 LUNG DISORDER 846
128 HAEMORRHAGE 838
129 THERAPY INTERRUPTED 834
130 MEMORY IMPAIRMENT 833
131 INCORRECT DOSE ADMINISTERED 830
132 DRUG INTOLERANCE 823
133 PERICARDIAL EFFUSION 821
134 ILLNESS 808
135 HYPERHIDROSIS 798
136 HYPOAESTHESIA 795
137 PARAESTHESIA 795
138 DEVICE ISSUE 792
139 CHRONIC KIDNEY DISEASE 784
140 MUSCULAR WEAKNESS 783
141 DIABETES MELLITUS 782
142 ASCITES 777
143 MALIGNANT MELANOMA 771
144 ACUTE RESPIRATORY FAILURE 765
145 CELLULITIS 764
146 HAEMOPTYSIS 764
147 SEASONAL ALLERGY 763
148 PLATELET COUNT DECREASED 759
149 TRANSFUSION 755
150 PRODUCT DOSE OMISSION 741
151 INTENTIONAL PRODUCT MISUSE 733
152 SLEEP DISORDER 716
153 INJECTION SITE PAIN 714
154 THERAPY CESSATION 713
155 WHEEZING 712
156 BLOOD TESTOSTERONE DECREASED 711
157 DRUG HYPERSENSITIVITY 700
158 RENAL IMPAIRMENT 688
159 BENIGN PROSTATIC HYPERPLASIA 686
160 UPPER RESPIRATORY TRACT INFECTION 679
161 INFUSION SITE HAEMORRHAGE 661
162 INFUSION SITE INFECTION 657
163 NECK PAIN 644
164 TINNITUS 644
165 THROMBOSIS 642
166 TREATMENT NONCOMPLIANCE 637
167 PRESYNCOPE 624
168 DYSPHONIA 615
169 DEPRESSED MOOD 611
170 OVERDOSE 605
171 VASCULAR DEVICE INFECTION 600
172 DEVICE LEAKAGE 599
173 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 594
174 CONTUSION 593
175 DRY MOUTH 583
176 INFLUENZA LIKE ILLNESS 581
177 SWELLING FACE 579
178 FEELING HOT 578
179 CATHETERISATION CARDIAC 577
180 FLATULENCE 569
181 PULMONARY EMBOLISM 568
182 VIRAL INFECTION 558
183 ARTHRITIS 556
184 CATHETER SITE ERYTHEMA 544
185 MUSCULOSKELETAL PAIN 544
186 URTICARIA 544
187 PRODUCT USE IN UNAPPROVED INDICATION 542
188 BLOOD POTASSIUM DECREASED 540
189 TOXICITY TO VARIOUS AGENTS 539
190 BLOOD CREATININE INCREASED 533
191 DEVICE OCCLUSION 531
192 OXYGEN CONSUMPTION INCREASED 530
193 POLLAKIURIA 529
194 BALANCE DISORDER 522
195 RENAL DISORDER 522
196 LUNG TRANSPLANT 515
197 SEIZURE 511
198 LETHARGY 508
199 BLOOD GLUCOSE INCREASED 507
200 DEVICE MALFUNCTION 507
201 INTERSTITIAL LUNG DISEASE 494
202 SURGERY 491
203 STRESS 480
204 DYSPHAGIA 478
205 ASTHMA 475
206 ADVERSE EVENT 474
207 SCLERODERMA 464
208 THROMBOCYTOPENIA 463
209 HEAD INJURY 460
210 HAEMATOCHEZIA 458
211 CATHETER SITE PAIN 456
212 HYPOACUSIS 453
213 NEUROPATHY PERIPHERAL 453
214 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 452
215 ASPARTATE AMINOTRANSFERASE INCREASED 451
216 INFUSION SITE DISCHARGE 446
217 PULMONARY ARTERIAL PRESSURE INCREASED 446
218 ALANINE AMINOTRANSFERASE INCREASED 445
219 RESPIRATORY DISTRESS 443
220 SINUS DISORDER 442
221 DRUG ABUSE 439
222 INJECTION SITE ERYTHEMA 439
223 HYPERVOLAEMIA 434
224 OCULAR HYPERAEMIA 434
225 ARRHYTHMIA 426
226 CATARACT 425
227 DEVICE INFUSION ISSUE 418
228 INTENTIONAL PRODUCT USE ISSUE 418
229 BRAIN NATRIURETIC PEPTIDE INCREASED 416
230 COMPLICATION ASSOCIATED WITH DEVICE 407
231 DEAFNESS 407
232 SINUS CONGESTION 407
233 STAPHYLOCOCCAL INFECTION 403
234 LIBIDO DECREASED 402
235 GOUT 401
236 HYPOKALAEMIA 396
237 LOCALISED INFECTION 396
238 EYE PAIN 394
239 ALOPECIA 392
240 VERTIGO 390
241 RECTAL HAEMORRHAGE 386
242 THERAPY CHANGE 385
243 CORONARY ARTERY DISEASE 382
244 CLOSTRIDIUM DIFFICILE INFECTION 381
245 DRY SKIN 380
246 BONE PAIN 379
247 CARDIO-RESPIRATORY ARREST 376
248 RESPIRATORY DISORDER 376
249 ADVERSE DRUG REACTION 375
250 MUSCULOSKELETAL STIFFNESS 372
251 AMNESIA 367
252 INFUSION SITE PRURITUS 366
253 TRANSIENT ISCHAEMIC ATTACK 359
254 CYANOSIS 358
255 HEART RATE DECREASED 358
256 DIZZINESS POSTURAL 357
257 HIP FRACTURE 356
258 HERPES ZOSTER 355
259 SEPTIC SHOCK 355
260 WHITE BLOOD CELL COUNT DECREASED 355
261 CATHETER SITE INFECTION 352
262 LIVER DISORDER 351
263 PREMATURE BABY 351
264 BLINDNESS 349
265 DIALYSIS 349
266 INTENTIONAL DOSE OMISSION 347
267 EMOTIONAL DISTRESS 345
268 BURNING SENSATION 343
269 DEVICE FAILURE 343
270 PNEUMOTHORAX 342
271 RASH PRURITIC 341
272 CATHETER SITE HAEMORRHAGE 340
273 DISCOMFORT 335
274 PRODUCT SUBSTITUTION ISSUE 334
275 PROSTATE CANCER 333
276 GASTRIC DISORDER 332
277 EXPOSURE DURING PREGNANCY 330
278 BRADYCARDIA 329
279 RESPIRATORY TRACT INFECTION 329
280 HEPATIC CIRRHOSIS 327
281 NEOPLASM MALIGNANT 327
282 CEREBRAL HAEMORRHAGE 326
283 ROAD TRAFFIC ACCIDENT 326
284 RESPIRATORY TRACT CONGESTION 325
285 CATHETER MANAGEMENT 324
286 PULMONARY CONGESTION 324
287 EAR INFECTION 323
288 FOETAL EXPOSURE DURING PREGNANCY 323
289 INFUSION SITE REACTION 323
290 EXERCISE TOLERANCE DECREASED 322
291 CATHETER SITE DISCHARGE 321
292 CATHETER SITE PRURITUS 321
293 DYSURIA 321
294 MATERNAL EXPOSURE DURING PREGNANCY 321
295 DYSGEUSIA 319
296 CENTRAL VENOUS CATHETERISATION 316
297 FEELING COLD 316
298 EYE SWELLING 315
299 SYSTEMIC LUPUS ERYTHEMATOSUS 315
300 GASTROENTERITIS VIRAL 314
301 CONCOMITANT DISEASE AGGRAVATED 312
302 HEAD DISCOMFORT 312
303 LIBIDO DISORDER 311
304 AGITATION 309
305 BLOOD PRESSURE ABNORMAL 309
306 LIMB DISCOMFORT 309
307 MOBILITY DECREASED 308
308 RESPIRATION ABNORMAL 308
309 SLEEP APNOEA SYNDROME 306
310 INFUSION SITE INDURATION 304
311 NERVOUSNESS 303
312 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 302
313 ATRIAL FLUTTER 301
314 SECRETION DISCHARGE 294
315 RETCHING 290
316 DEVICE USE ERROR 288
317 LIMB INJURY 288
318 PANCREATITIS 288
319 SKIN DISCOLOURATION 287
320 HEART RATE IRREGULAR 286
321 MENTAL STATUS CHANGES 286
322 NEPHROLITHIASIS 283
323 DEVICE BREAKAGE 281
324 BLOOD IRON DECREASED 279
325 MALIGNANT MELANOMA IN SITU 279
326 COMA 278
327 HAEMOGLOBIN INCREASED 278
328 BLOOD BILIRUBIN INCREASED 277
329 HYPONATRAEMIA 274
330 INTENTIONAL OVERDOSE 272
331 INTESTINAL OBSTRUCTION 272
332 VISUAL ACUITY REDUCED 272
333 CARDIOMEGALY 271
334 HAEMATEMESIS 270
335 BLISTER 269
336 INTERNATIONAL NORMALISED RATIO INCREASED 269
337 HYPERSOMNIA 268
338 INFUSION SITE IRRITATION 267
339 DYSPNOEA AT REST 266
340 PRODUCT ADMINISTRATION INTERRUPTED 265
341 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 264
342 CARDIAC OPERATION 262
343 END STAGE RENAL DISEASE 261
344 LACRIMATION INCREASED 261
345 DEVICE ALARM ISSUE 260
346 HAEMATOCRIT DECREASED 260
347 PULMONARY FIBROSIS 260
348 IRON DEFICIENCY ANAEMIA 259
349 ACCIDENTAL OVERDOSE 258
350 DECREASED ACTIVITY 258
351 FAECES DISCOLOURED 257
352 INFUSION SITE WARMTH 257
353 PALLOR 257
354 HALLUCINATION 256
355 BLOOD ALKALINE PHOSPHATASE INCREASED 254
356 PREMATURE DELIVERY 253
357 EXTRA DOSE ADMINISTERED 252
358 CATHETER PLACEMENT 251
359 HEPATIC ENZYME INCREASED 249
360 DEEP VEIN THROMBOSIS 247
361 LIP SWELLING 247
362 LIVER FUNCTION TEST ABNORMAL 246
363 ANGINA PECTORIS 245
364 RED BLOOD CELL COUNT DECREASED 245
365 UNDERDOSE 245
366 FREQUENT BOWEL MOVEMENTS 244
367 CHOLELITHIASIS 243
368 HYPOGLYCAEMIA 242
369 NO ADVERSE EVENT 242
370 CARDIOGENIC SHOCK 240
371 DIVERTICULITIS 240
372 LOWER RESPIRATORY TRACT INFECTION 240
373 SUICIDAL IDEATION 240
374 RESPIRATORY SYNCYTIAL VIRUS INFECTION 238
375 PSORIASIS 237
376 ACUTE MYOCARDIAL INFARCTION 236
377 INJECTION SITE HAEMORRHAGE 236
378 INTERNAL HAEMORRHAGE 236
379 DEVICE MAINTENANCE ISSUE 235
380 UNRESPONSIVE TO STIMULI 235
381 DIPLOPIA 234
382 SKIN ULCER 234
383 DISTURBANCE IN ATTENTION 233
384 NEURALGIA 232
385 ILL-DEFINED DISORDER 230
386 MULTIPLE ORGAN DYSFUNCTION SYNDROME 230
387 PANCYTOPENIA 230
388 RIB FRACTURE 228
389 PRIAPISM 227
390 LUNG NEOPLASM MALIGNANT 226
391 SKIN IRRITATION 226
392 IRRITABILITY 225
393 EYE DISORDER 224
394 OBSTRUCTIVE AIRWAYS DISORDER 224
395 NIGHT SWEATS 222
396 INJECTION SITE SWELLING 220
397 PURULENT DISCHARGE 220
398 COMPLETED SUICIDE 219
399 EYE IRRITATION 219
400 SNEEZING 219
401 INJECTION SITE PRURITUS 217
402 BACTERAEMIA 216
403 INFLAMMATION 216
404 PNEUMONIA ASPIRATION 216
405 RASH ERYTHEMATOUS 216
406 BLOOD GLUCOSE DECREASED 215
407 EAR DISCOMFORT 215
408 FAECES SOFT 215
409 RESTLESS LEGS SYNDROME 215
410 SPEECH DISORDER 215
411 BODY HEIGHT DECREASED 212
412 HEPATIC FUNCTION ABNORMAL 210
413 MEDICATION ERROR 210
414 HAEMORRHOIDS 209
415 JOINT INJURY 209
416 INJECTION SITE DISCHARGE 208
417 LYMPHADENOPATHY 208
418 WHITE BLOOD CELL COUNT INCREASED 208
419 CARDIAC PACEMAKER INSERTION 207
420 DRY EYE 207
421 LUNG INFECTION 206
422 POOR QUALITY SLEEP 205
423 OSTEOPOROSIS 204
424 SKIN EXFOLIATION 204
425 CYSTITIS 201
426 GENERALISED OEDEMA 200
427 MUSCULOSKELETAL CHEST PAIN 200
428 RHEUMATOID ARTHRITIS 198
429 ANHEDONIA 197
430 COLITIS 197
431 GAIT INABILITY 197
432 LIVER FUNCTION TEST INCREASED 197
433 MELAENA 197
434 PRODUCT QUALITY ISSUE 197
435 ERECTION INCREASED 196
436 OPTIC ISCHAEMIC NEUROPATHY 196
437 SUSPECTED COUNTERFEIT PRODUCT 196
438 ANGIOEDEMA 195
439 CARDIAC FAILURE ACUTE 195
440 KIDNEY INFECTION 195
441 EAR PAIN 194
442 BLOOD PRESSURE FLUCTUATION 193
443 OSTEOARTHRITIS 193
444 HERNIA 192
445 MUSCULOSKELETAL DISCOMFORT 188
446 NEUTROPENIA 188
447 PANIC ATTACK 188
448 COGNITIVE DISORDER 187
449 HEPATIC FAILURE 187
450 RASH MACULAR 187
451 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 186
452 WEIGHT FLUCTUATION 186
453 BLOOD COUNT ABNORMAL 185
454 PULMONARY VENO-OCCLUSIVE DISEASE 185
455 URINARY RETENTION 184
456 VENTRICULAR TACHYCARDIA 184
457 BACTERIAL INFECTION 183
458 BRAIN FOG 183
459 CIRCULATORY COLLAPSE 183
460 HYPERKALAEMIA 183
461 LOCALISED OEDEMA 183
462 POST PROCEDURAL COMPLICATION 182
463 PHOTOPHOBIA 181
464 THERAPY PARTIAL RESPONDER 181
465 GASTRITIS 180
466 DEVICE RELATED SEPSIS 179
467 CATHETER SITE SWELLING 178
468 TRANSPLANT EVALUATION 178
469 TOOTHACHE 177
470 DEAFNESS UNILATERAL 176
471 WOUND 176
472 DISORIENTATION 175
473 SUPRAVENTRICULAR TACHYCARDIA 175
474 HAEMATURIA 174
475 GALLBLADDER DISORDER 173
476 BLOOD SODIUM DECREASED 172
477 LABORATORY TEST ABNORMAL 172
478 UPPER LIMB FRACTURE 172
479 EYE PRURITUS 171
480 ERUCTATION 170
481 MENTAL DISORDER 170
482 PULMONARY HAEMORRHAGE 170
483 SKIN DISORDER 170
484 INFUSION SITE RASH 169
485 ARTHROPATHY 168
486 QUALITY OF LIFE DECREASED 167
487 SUBARACHNOID HAEMORRHAGE 167
488 SUBDURAL HAEMATOMA 167
489 URINARY INCONTINENCE 167
490 DYSLIPIDAEMIA 166
491 EYE HAEMORRHAGE 166
492 INJECTION SITE INFECTION 166
493 RESTLESSNESS 166
494 TREATMENT FAILURE 166
495 FUNGAL INFECTION 165
496 TRICUSPID VALVE INCOMPETENCE 165
497 INJURY 164
498 MICTURITION URGENCY 163
499 STENT PLACEMENT 162
500 C-REACTIVE PROTEIN INCREASED 161
501 DELIRIUM 161
502 DYSSTASIA 161
503 SENSATION OF FOREIGN BODY 161
504 BASAL CELL CARCINOMA 160
505 RESPIRATORY ARREST 160
506 EOSINOPHILIA 159
507 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 159
508 LEFT VENTRICULAR FAILURE 158
509 THROAT TIGHTNESS 158
510 UPPER GASTROINTESTINAL HAEMORRHAGE 158
511 BLOOD POTASSIUM INCREASED 157
512 HAEMATOMA 157
513 LIVER TRANSPLANT 157
514 HOSPICE CARE 156
515 RENAL INJURY 156
516 CHROMATURIA 155
517 GASTROENTERITIS 155
518 RIGHT VENTRICULAR DYSFUNCTION 155
519 EXPIRED PRODUCT ADMINISTERED 154
520 ISCHAEMIC STROKE 154
521 ORTHOSTATIC HYPOTENSION 154
522 THROMBOSIS IN DEVICE 154
523 WRONG TECHNIQUE IN DRUG USAGE PROCESS 154
524 BLOOD UREA INCREASED 153
525 MOOD ALTERED 153
526 PRODUCT DOSE OMISSION IN ERROR 153
527 THERAPEUTIC RESPONSE UNEXPECTED 153
528 BLINDNESS UNILATERAL 152
529 GAMMA-GLUTAMYLTRANSFERASE INCREASED 152
530 AGEUSIA 151
531 SUDDEN DEATH 151
532 SPINAL FRACTURE 150
533 BREAST CANCER 149
534 NOCTURIA 149
535 SCIATICA 149
536 CATHETER SITE RASH 148
537 PULMONARY THROMBOSIS 148
538 INFUSION SITE OEDEMA 147
539 SPUTUM DISCOLOURED 147
540 DEVICE CONNECTION ISSUE 146
541 NO THERAPEUTIC RESPONSE 146
542 TASTE DISORDER 146
543 HIP ARTHROPLASTY 145
544 AGGRESSION 144
545 DEMENTIA 144
546 DEVICE DIFFICULT TO USE 144
547 POLYURIA 144
548 RHABDOMYOLYSIS 144
549 SLUGGISHNESS 144
550 DYSARTHRIA 143
551 JAUNDICE 143
552 HYPOPHAGIA 142
553 OBSTRUCTIVE SLEEP APNOEA SYNDROME 142
554 OXYGEN SATURATION ABNORMAL 142
555 SKIN INFECTION 142
556 BLOOD URINE PRESENT 141
557 INFUSION SITE NODULE 141
558 DISEASE COMPLICATION 140
559 CHOKING 139
560 FEEDING DISORDER 139
561 KNEE ARTHROPLASTY 139
562 PLANTAR FASCIITIS 139
563 RHINOVIRUS INFECTION 139
564 DRUG-INDUCED LIVER INJURY 138
565 RENAL FAILURE ACUTE 138
566 STOMATITIS 138
567 VAGINAL HAEMORRHAGE 138
568 DEVICE POWER SOURCE ISSUE 137
569 FACIAL PAIN 137
570 NASAL DRYNESS 137
571 APHASIA 136
572 LOWER LIMB FRACTURE 136
573 RALES 136
574 ACCIDENTAL EXPOSURE TO PRODUCT 135
575 DEVICE WIRELESS COMMUNICATION ISSUE 135
576 FEELING JITTERY 135
577 METABOLIC ACIDOSIS 135
578 BLOOD PRESSURE SYSTOLIC DECREASED 134
579 BODY TEMPERATURE INCREASED 134
580 EXOSTOSIS 134
581 PULMONARY ALVEOLAR HAEMORRHAGE 134
582 ANKLE FRACTURE 133
583 BACK DISORDER 133
584 BRONCHOSPASM 133
585 ECZEMA 133
586 GLAUCOMA 133
587 INFUSION SITE DISCOMFORT 133
588 COLD SWEAT 132
589 TACHYPNOEA 132
590 HYPERTHYROIDISM 131
591 INFUSION SITE EXTRAVASATION 131
592 URINE OUTPUT DECREASED 131
593 DRUG EFFECT DECREASED 130
594 MUSCLE TIGHTNESS 130
595 PULMONARY HYPERTENSIVE CRISIS 130
596 COVID-19 PNEUMONIA 129
597 MYOGLOBIN BLOOD INCREASED 129
598 PULMONARY MASS 129
599 CARDIAC FLUTTER 128
600 ELECTROLYTE IMBALANCE 128
601 PROSTATIC SPECIFIC ANTIGEN INCREASED 128
602 SINUS HEADACHE 128
603 BEDRIDDEN 127
604 SUBSTANCE USE DISORDER 127
605 THERAPEUTIC PRODUCT EFFECT DECREASED 127
606 FEMUR FRACTURE 126
607 INFUSION SITE DISCOLOURATION 126
608 NEPHROGENIC ANAEMIA 126
609 ORTHOPNOEA 126
610 SMALL INTESTINAL OBSTRUCTION 126
611 UPPER-AIRWAY COUGH SYNDROME 126
612 FRACTIONAL EXHALED NITRIC OXIDE INCREASED 125
613 INFUSION SITE INFLAMMATION 125
614 GINGIVAL BLEEDING 124
615 PERIPHERAL COLDNESS 124
616 SWOLLEN TONGUE 124
617 FOOT FRACTURE 123
618 HAEMODYNAMIC INSTABILITY 123
619 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 123
620 RAYNAUD^S PHENOMENON 123
621 EJACULATION FAILURE 122
622 FLANK PAIN 122
623 ANAPHYLACTIC REACTION 121
624 COLON CANCER 120
625 INJECTION SITE BRUISING 120
626 SKIN LACERATION 120
627 WALKING DISTANCE TEST ABNORMAL 120
628 CHOLECYSTECTOMY 119
629 TOOTH INFECTION 119
630 ECONOMIC PROBLEM 118
631 MULTIPLE ALLERGIES 118
632 PARANASAL SINUS DISCOMFORT 118
633 PENIS DISORDER 118
634 ACUTE RESPIRATORY DISTRESS SYNDROME 117
635 IMPAIRED GASTRIC EMPTYING 117
636 OCULAR DISCOMFORT 117
637 ORAL PAIN 117
638 TERMINAL STATE 117
639 BREATH SOUNDS ABNORMAL 116
640 DEPRESSED LEVEL OF CONSCIOUSNESS 116
641 PNEUMONIA BACTERIAL 116
642 SHOCK 116
643 TOOTH DISORDER 116
644 CONVULSION 115
645 DRUG DEPENDENCE 115
646 DYSKINESIA 115
647 GASTRIC HAEMORRHAGE 115
648 IMPAIRED HEALING 115
649 RETINAL DETACHMENT 115
650 ATRIAL TACHYCARDIA 114
651 DEVICE PHYSICAL PROPERTY ISSUE 114
652 HIATUS HERNIA 114
653 PRODUCT LEAKAGE 114
654 THIRST 114
655 ACNE 113
656 DISEASE RECURRENCE 113
657 ENCEPHALOPATHY 113
658 FACE OEDEMA 113
659 PANCREATITIS ACUTE 113
660 ATELECTASIS 112
661 HYPERGLYCAEMIA 112
662 HYPOTHYROIDISM 112
663 INFUSION RELATED REACTION 112
664 INJECTION SITE RASH 112
665 OXYGEN THERAPY 112
666 ULCER 112
667 UNINTENTIONAL MEDICAL DEVICE REMOVAL 112
668 URINE FLOW DECREASED 112
669 ABSCESS 111
670 CARDIOVASCULAR DISORDER 111
671 CHOKING SENSATION 111
672 CRYING 111
673 MUSCLE TWITCHING 111
674 OSTEOMYELITIS 111
675 PULMONARY PAIN 111
676 SARS-COV-2 TEST POSITIVE 111
677 ANGER 110
678 CLOSTRIDIUM DIFFICILE COLITIS 110
679 ANOSMIA 109
680 HEPATIC ENCEPHALOPATHY 109
681 JOINT STIFFNESS 109
682 APHONIA 108
683 HEPATIC STEATOSIS 108
684 INTERVERTEBRAL DISC PROTRUSION 108
685 MOVEMENT DISORDER 108
686 NIGHTMARE 108
687 CARDIAC FAILURE CHRONIC 107
688 LARGE INTESTINE POLYP 107
689 AMMONIA INCREASED 106
690 ANAL INCONTINENCE 106
691 BACK INJURY 106
692 FULL BLOOD COUNT DECREASED 106
693 GASTRIC ULCER 106
694 GYNAECOMASTIA 106
695 LIGAMENT SPRAIN 106
696 MIDDLE INSOMNIA 106
697 PSORIATIC ARTHROPATHY 106
698 ABNORMAL BEHAVIOUR 105
699 DEVICE USE ISSUE 105
700 PNEUMONITIS 105
701 HEPATOMEGALY 104
702 LOSS OF LIBIDO 104
703 OROPHARYNGEAL DISCOMFORT 104
704 PAIN OF SKIN 104
705 SQUAMOUS CELL CARCINOMA 104
706 SYSTEMIC SCLERODERMA 104
707 ANORGASMIA 103
708 FULL BLOOD COUNT ABNORMAL 103
709 INSURANCE ISSUE 103
710 MECHANICAL VENTILATION 103
711 SPONTANEOUS PENILE ERECTION 103
712 TUBULOINTERSTITIAL NEPHRITIS 103
713 ASPIRATION 102
714 BLOOD CREATINE PHOSPHOKINASE INCREASED 102
715 CARDIAC ABLATION 102
716 IRRITABLE BOWEL SYNDROME 102
717 MENTAL IMPAIRMENT 102
718 MOOD SWINGS 102
719 MUSCLE STRAIN 102
720 POST PROCEDURAL HAEMORRHAGE 102
721 CANDIDA INFECTION 101
722 VISUAL FIELD DEFECT 101
723 ABDOMINAL PAIN LOWER 100
724 BLADDER CANCER 100
725 CONTRAINDICATED PRODUCT ADMINISTERED 100
726 DRY THROAT 100
727 PERICARDITIS 100
728 RIGHT VENTRICULAR DILATATION 100
729 TOOTH EXTRACTION 100
730 CORONARY ARTERY OCCLUSION 99
731 HEART RATE ABNORMAL 99
732 INFUSION SITE BRUISING 99
733 INJECTION SITE IRRITATION 99
734 INJECTION SITE REACTION 99
735 HEMIPARESIS 98
736 INFUSION SITE VESICLES 98
737 NASAL DISCOMFORT 98
738 PARACENTESIS 98
739 TROPONIN INCREASED 98
740 CHOLECYSTITIS 97
741 COLITIS ULCERATIVE 97
742 EMPHYSEMA 97
743 MALIGNANT MELANOMA STAGE I 97
744 CEREBRAL INFARCTION 96
745 DRUG WITHDRAWAL SYNDROME 96
746 INFUSION SITE CELLULITIS 96
747 LACERATION 96
748 LARYNGITIS 96
749 SPINAL OPERATION 96
750 APPLICATION SITE PRURITUS 95
751 BLOOD CULTURE POSITIVE 95
752 BONE DENSITY DECREASED 95
753 CATHETER SITE IRRITATION 95
754 OSTEOPENIA 95
755 PROCEDURAL PAIN 95
756 PULSELESS ELECTRICAL ACTIVITY 95
757 SUICIDE ATTEMPT 95
758 TYPE 2 DIABETES MELLITUS 95
759 VENTRICULAR FIBRILLATION 95
760 BLOOD TEST ABNORMAL 94
761 CATHETER SITE INFLAMMATION 94
762 LOCAL SWELLING 94
763 PLASMA CELL MYELOMA 94
764 SEXUAL DYSFUNCTION 94
765 SKIN LESION 94
766 THYROID DISORDER 94
767 COAGULOPATHY 93
768 EATING DISORDER 93
769 EYE INFECTION 93
770 HAEMORRHAGE INTRACRANIAL 93
771 INCREASED UPPER AIRWAY SECRETION 93
772 PRODUCT ADMINISTRATION ERROR 93
773 VIRAL UPPER RESPIRATORY TRACT INFECTION 93
774 DRUG TITRATION ERROR 92
775 GENERALISED TONIC-CLONIC SEIZURE 92
776 MIDDLE EAR EFFUSION 92
777 ORAL CANDIDIASIS 92
778 PHARYNGITIS STREPTOCOCCAL 92
779 SCAR 92
780 SKIN BURNING SENSATION 92
781 SPLENOMEGALY 92
782 EMOTIONAL DISORDER 91
783 LIVER INJURY 90
784 MEDICAL DEVICE COMPLICATION 90
785 PREGNANCY 90
786 TENSION HEADACHE 90
787 TRANSAMINASES INCREASED 90
788 EPILEPSY 89
789 INTRAOCULAR PRESSURE INCREASED 89
790 MACULAR DEGENERATION 89
791 BLOOD PRESSURE SYSTOLIC INCREASED 88
792 COR PULMONALE 88
793 EAR CONGESTION 88
794 HAEMORRHOIDAL HAEMORRHAGE 88
795 MENORRHAGIA 88
796 NEPHROPATHY 88
797 PARKINSON^S DISEASE 88
798 PELVIC FRACTURE 88
799 SCAB 88
800 ABNORMAL DREAMS 87
801 BLOOD MAGNESIUM DECREASED 87
802 FEBRILE NEUTROPENIA 87
803 INTENTIONAL DRUG MISUSE 87
804 IRON DEFICIENCY 87
805 PARANASAL SINUS HYPERSECRETION 87
806 PRESCRIBED OVERDOSE 87
807 TOOTH ABSCESS 87
808 ULCER HAEMORRHAGE 87
809 VITREOUS FLOATERS 87
810 BOWEL MOVEMENT IRREGULARITY 86
811 DIZZINESS EXERTIONAL 86
812 IDIOPATHIC PULMONARY FIBROSIS 86
813 MALNUTRITION 86
814 PACKED RED BLOOD CELL TRANSFUSION 86
815 PHARYNGITIS 86
816 RASH GENERALISED 86
817 ROTATOR CUFF SYNDROME 86
818 CROHN^S DISEASE 85
819 GLOMERULAR FILTRATION RATE DECREASED 85
820 INCORRECT DRUG ADMINISTRATION RATE 85
821 BRONCHIECTASIS 84
822 FIBROMYALGIA 84
823 GLYCOSYLATED HAEMOGLOBIN INCREASED 84
824 GROIN PAIN 84
825 MALIGNANT NEOPLASM PROGRESSION 84
826 MULTIPLE SCLEROSIS RELAPSE 84
827 THERAPEUTIC RESPONSE INCREASED 84
828 DRUG ADMINISTRATION ERROR 83
829 MITRAL VALVE INCOMPETENCE 83
830 MOUTH HAEMORRHAGE 83
831 RASH PAPULAR 83
832 RENAL PAIN 83
833 RHINITIS 83
834 BLOOD GLUCOSE ABNORMAL 82
835 ECHOCARDIOGRAM ABNORMAL 82
836 ENDOTRACHEAL INTUBATION 82
837 KNEE OPERATION 82
838 OBESITY 82
839 ATRIAL SEPTAL DEFECT 81
840 DRUG EFFECT INCOMPLETE 81
841 ELECTROCARDIOGRAM QT PROLONGED 81
842 HEART TRANSPLANT 81
843 INFUSION SITE ABSCESS 81
844 LEUKOPENIA 81
845 LOW BIRTH WEIGHT BABY 81
846 MUSCLE ATROPHY 81
847 PARANOIA 81
848 PRODUCT USE COMPLAINT 81
849 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 81
850 CHRONIC RESPIRATORY FAILURE 80
851 MALIGNANT MELANOMA STAGE IV 80
852 VASCULITIS 80
853 AUTOIMMUNE DISORDER 79
854 CARDIOMYOPATHY 79
855 HYPERLIPIDAEMIA 79
856 INCREASED APPETITE 79
857 INFUSION SITE MASS 79
858 INITIAL INSOMNIA 79
859 LEUKOCYTOSIS 79
860 OESOPHAGITIS 79
861 PROCEDURAL COMPLICATION 79
862 PRURITUS GENERALISED 79
863 WRIST FRACTURE 79
864 ACCIDENT 78
865 BLINDNESS TRANSIENT 78
866 FEAR 78
867 HYSTERECTOMY 78
868 MULTI-ORGAN FAILURE 78
869 ABASIA 77
870 HYPERCHOLESTEROLAEMIA 77
871 HYPERPARATHYROIDISM SECONDARY 77
872 MYOCARDIAL ISCHAEMIA 77
873 PROSTATOMEGALY 77
874 SINUS TACHYCARDIA 77
875 CARPAL TUNNEL SYNDROME 76
876 CONJUNCTIVITIS 76
877 DRUG TOLERANCE DECREASED 76
878 GASTROINTESTINAL INFECTION 76
879 TRANSPLANT 76
880 CARDIOPULMONARY FAILURE 75
881 MALIGNANT MELANOMA STAGE II 75
882 SKIN CANCER 75
883 VASODILATATION 75
884 ACTINIC KERATOSIS 74
885 METASTATIC MALIGNANT MELANOMA 74
886 PHOTOSENSITIVITY REACTION 74
887 SENSORY DISTURBANCE 74
888 ALTERED STATE OF CONSCIOUSNESS 73
889 APPENDICITIS 73
890 BRAIN INJURY 73
891 CARBON DIOXIDE INCREASED 73
892 PRODUCT SUPPLY ISSUE 73
893 SPINAL COMPRESSION FRACTURE 73
894 STAPHYLOCOCCAL BACTERAEMIA 73
895 APATHY 72
896 BLADDER DISORDER 72
897 CARDIAC TAMPONADE 72
898 CARDIAC VALVE DISEASE 72
899 CYANOPSIA 72
900 HYPERCAPNIA 72
901 INCORRECT DOSE ADMINISTERED BY DEVICE 72
902 LUNG INFILTRATION 72
903 PNEUMONIA VIRAL 72
904 PRODUCT AVAILABILITY ISSUE 72
905 ACUTE PULMONARY OEDEMA 71
906 CAESAREAN SECTION 71
907 DRUG ERUPTION 71
908 FRACTURE 71
909 VISUAL DISTURBANCE 71
910 BLOOD PRESSURE DIASTOLIC DECREASED 70
911 CONCOMITANT DISEASE PROGRESSION 70
912 CONCUSSION 70
913 EYELID OEDEMA 70
914 ILEUS 70
915 LOWER GASTROINTESTINAL HAEMORRHAGE 70
916 MULTIPLE SCLEROSIS 70
917 NOCTURNAL DYSPNOEA 70
918 OSTEONECROSIS 70
919 PHOTOPSIA 70
920 WITHDRAWAL SYNDROME 70
921 AORTIC STENOSIS 69
922 CHOLESTASIS 69
923 DERMATITIS ATOPIC 69
924 EJACULATION DISORDER 69
925 FOOD POISONING 69
926 PERFORMANCE STATUS DECREASED 69
927 PORTAL HYPERTENSION 69
928 PROSTATITIS 69
929 PULMONARY ARTERIAL PRESSURE ABNORMAL 69
930 RESPIRATORY RATE INCREASED 69
931 STAPHYLOCOCCUS TEST POSITIVE 69
932 UPPER RESPIRATORY TRACT CONGESTION 69
933 APPLICATION SITE ERYTHEMA 68
934 CARDIOVERSION 68
935 PRODUCT DISTRIBUTION ISSUE 68
936 SCRATCH 68
937 TELANGIECTASIA 68
938 TESTICULAR PAIN 68
939 ABNORMAL LOSS OF WEIGHT 67
940 DIABETES MELLITUS INADEQUATE CONTROL 67
941 IMPAIRED QUALITY OF LIFE 67
942 INJECTION SITE INDURATION 67
943 POLYP 67
944 TEMPERATURE INTOLERANCE 67
945 TENDONITIS 67
946 TRACHEOSTOMY 67
947 DRUG LEVEL INCREASED 66
948 ELECTROCARDIOGRAM ABNORMAL 66
949 HYPOAESTHESIA ORAL 66
950 PETECHIAE 66
951 UROSEPSIS 66
952 ASPIRATION PLEURAL CAVITY 65
953 DIVERTICULUM 65
954 GLOSSODYNIA 65
955 INJECTION SITE MASS 65
956 INTERNATIONAL NORMALISED RATIO DECREASED 65
957 PRODUCT PRESCRIBING ISSUE 65
958 SARCOIDOSIS 65
959 SKIN ABRASION 65
960 AORTIC ANEURYSM 64
961 APPETITE DISORDER 64
962 BLOOD LOSS ANAEMIA 64
963 CATARACT OPERATION 64
964 CATHETER SITE RELATED REACTION 64
965 CHEMOTHERAPY 64
966 DEVICE ADHESION ISSUE 64
967 HERNIA REPAIR 64
968 HYPERBILIRUBINAEMIA 64
969 PANCREATIC CARCINOMA 64
970 PENILE PAIN 64
971 SUDDEN HEARING LOSS 64
972 ASPHYXIA 63
973 CATHETER SITE VESICLES 63
974 DIASTOLIC DYSFUNCTION 63
975 HYPOKINESIA 63
976 MASS 63
977 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 63
978 PSYCHOTIC DISORDER 63
979 THINKING ABNORMAL 63
980 VARICOSE VEIN 63
981 BREAST PAIN 62
982 CARDIAC MURMUR 62
983 EMERGENCY CARE 62
984 EXPOSURE VIA SKIN CONTACT 62
985 HAEMATOCRIT INCREASED 62
986 INTERVERTEBRAL DISC DEGENERATION 62
987 INTESTINAL HAEMORRHAGE 62
988 PARAESTHESIA ORAL 62
989 RETINAL VEIN OCCLUSION 62
990 TRISMUS 62
991 VITAMIN D DECREASED 62
992 DERMATITIS ALLERGIC 61
993 DIABETIC KETOACIDOSIS 61
994 ENDOCARDITIS 61
995 GASTROINTESTINAL PAIN 61
996 NERVE COMPRESSION 61
997 NERVOUS SYSTEM DISORDER 61
998 PERIORBITAL SWELLING 61
999 VENTILATION PERFUSION MISMATCH 61